Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

Clinical trial NCT06926192 · RECRUITING

Trial details

NCT number: NCT06926192
Sponsor: Peking Union Medical College
Status: RECRUITING
Study type: OBSERVATIONAL

Hidradenitis Suppurativa (HS)Hidradenitis Suppurativa (Acne Inversa)Secukinumab

Start date: 2020-01-01
Primary completion: 2024-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.